An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy

被引:0
|
作者
De Caro, Francesco [1 ,2 ,3 ]
Pecoraro, Nadia [1 ]
Capunzo, Mario [2 ,3 ]
Caruccio, Simona [2 ]
Caggiano, Filippo [3 ]
Cersosimo, Giuseppina [4 ]
Costantino, Maria [2 ,3 ]
Longanella, Walter [3 ]
Malatesta, Francesca [1 ]
Tomeo, Matteo [2 ]
Savarese, Giulia [2 ]
Sinopoli, Pio [2 ]
Vozzella, Emilia Anna [3 ]
Moccia, Giuseppina [1 ]
机构
[1] Univ Salerno, Dept Med & Surg & Dent, Publ Hlth Lab Anal Community Hlth Needs, Baronissi Campus, I-84081 Baronissi, Italy
[2] Univ Salerno, Dept Med Surg & Dent, Baronissi Campus, I-84081 Baronissi, Italy
[3] Hosp San Giovanni Dio & Ruggi Aragona, I-84131 Salerno, Italy
[4] Univ Salerno, Dept Polit & Social Studies, I-84084 Fisciano, Italy
来源
PATHOGENS | 2025年 / 14卷 / 02期
关键词
Herpes Zoster; illness representations; vaccination; hospital vaccination; fragile patients; vaccinal campaigns; vaccine hesitancy; SUBUNIT VACCINE; EFFICACY;
D O I
10.3390/pathogens14020145
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the context of the Italian National Herpes Zoster Vaccine program, an exploratory survey was conducted on a sample of fragile adult patients to investigate the representations of the disease and its prevention to build future local vaccination campaigns. An ad hoc questionnaire was administered to 271 fragile adult patients who had adjuvanted recombinant Herpes Zoster vaccination to detect the following: knowledge and perception of the disease and its risks; information sources and confidence in the information sources used; and perception of the Herpes Zoster vaccination. Fragile adult patients have the representation of Herpes Zoster as a serious disease (86.5%), and they consider themselves informed concerning symptoms and health effects. Women are more fearful of the impact of the disease (Chi-square = 10.03; DF = 3; p-value = 0.018), while those with a higher average age consider themselves less informed (R = -158; p-value = 0.039). The sources of information that contributed to the construction of illness representation are health personnel (73.5%), followed by the web and social web (14.7%), and media such as radio and TV (10.0%). Regarding the vaccine representation, fragile patients are confident about the vaccine and the science behind it and believe everyone should receive it. However, a high percentage (62.9%) fear side effects. Our analysis highlights that vaccination campaigns must be planned based on the target audience, individual and contextual needs, and representations of the disease, particularly when dealing with frail patients, to implement effective preventive interventions.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study
    Costantino, Maria
    Giudice, Valentina
    Moccia, Giuseppina
    Longanella, Walter
    Caruccio, Simona
    Tremiterra, Giuliana
    Sinopoli, Pio
    Benvenuto, David
    Serio, Bianca
    Malatesta, Francesca
    Pecoraro, Nadia
    Vozzella, Emilia Anna
    Rossiello, Riccardo
    Genovese, Giovanni
    De Caro, Francesco
    VACCINES, 2024, 12 (09)
  • [2] Shingrix - An Adjuvanted, Recombinant Herpes Zoster Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1535): : 195 - 196
  • [3] Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine
    Levin, Myron J.
    Weinberg, Adriana
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1509 - 1515
  • [4] Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
    Bruxvoort, Katia J.
    Qian, Lei
    Wu, Jun
    Florea, Ana
    Ackerson, Bradley
    Sy, Lina S.
    Daily, Leticia Vega
    Takhar, Harpreet
    Tseng, Hung Fu
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
  • [5] Presumed Herpes Zoster Ophthalmicus Reactivation Following Recombinant Zoster Vaccination
    Jabbour, Samir
    Shekhawat, Nakul S.
    Chen, Ariel
    Woreta, Fasika A.
    CORNEA, 2021, 40 (02) : 248 - 250
  • [6] The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥ 65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine
    Dagnew, Alemnew F.
    Klein, Nicola P.
    Herve, Caroline
    Kalema, George
    Di Paolo, Emmanuel
    Peterson, James
    Salaun, Bruno
    Schuind, Anne
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (07): : 1139 - 1146
  • [7] Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
    James, Stephanie F.
    Chahine, Elias B.
    Sucher, Allana J.
    Hanna, Cassandra
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (07) : 673 - 680
  • [8] Vaccination against the herpes zoster virus
    Marco, Jose Javier Gomez
    Martin, Susana Martin
    Herce, Pablo Aldaz
    Miranda, Ana Pilar Javierre
    Hernandez, Coro Sanchez
    ATENCION PRIMARIA, 2023, 55 (10):
  • [9] Corneal Allograft Rejection Associated With Herpes Zoster Recombinant Adjuvanted Vaccine
    Matoba, Alice
    CORNEA, 2022, 41 (06) : 772 - 774
  • [10] Herpes Zoster Vaccination
    Kim, Kyung Hoon
    KOREAN JOURNAL OF PAIN, 2013, 26 (03): : 242 - 248